Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Scientific (MLSS) Gains from Sales and Divestitures (2022 - 2025)

Historic Gains from Sales and Divestitures for Milestone Scientific (MLSS) over the last 4 years, with Q3 2025 value amounting to $337081.0.

  • Milestone Scientific's Gains from Sales and Divestitures fell 3397.33% to $337081.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $337081.0, marking a year-over-year decrease of 3397.33%. This contributed to the annual value of $693106.0 for FY2024, which is 22.34% down from last year.
  • Latest data reveals that Milestone Scientific reported Gains from Sales and Divestitures of $337081.0 as of Q3 2025, which was down 3397.33% from $337081.0 recorded in Q2 2025.
  • In the past 5 years, Milestone Scientific's Gains from Sales and Divestitures ranged from a high of $694658.0 in Q4 2023 and a low of $173443.0 during Q1 2024
  • Moreover, its 4-year median value for Gains from Sales and Divestitures was $337081.0 (2025), whereas its average is $387783.6.
  • Per our database at Business Quant, Milestone Scientific's Gains from Sales and Divestitures surged by 14023.3% in 2023 and then plummeted by 3928.94% in 2024.
  • Quarter analysis of 4 years shows Milestone Scientific's Gains from Sales and Divestitures stood at $449695.0 in 2022, then surged by 54.47% to $694658.0 in 2023, then fell by 0.22% to $693106.0 in 2024, then tumbled by 51.37% to $337081.0 in 2025.
  • Its last three reported values are $337081.0 in Q3 2025, $337081.0 for Q2 2025, and $182584.0 during Q1 2025.